First evaluation of a novel pulsatile LVAD: Feasibility and haemodynamic impact in acute heart failure - PulseCath

Skip to main content Skip to footer

Home
News
Clinical information
- Publications
Product iVAC 2L
Distributors
Support & Service
Academy
Our company

Search...

Home
News
Clinical information
- Publications
Product iVAC 2L
Distributors
Support & Service
Academy
Our company

ANY QUESTIONS?

Contact us

Save time by providing instant answers to the most frequently asked questions. If you can't find the answer you seek please don't hesitate to send us a direct message.

See our FAQs Send an email

Office & warehouse: De Corridor 5, 3621 ZA Breukelen, The Netherlands

info@pulsecath.com
www.pulsecath.com

Copyright © 2026 • PulseCath

Disclaimer
Privacy Policy

iVAC 2L Trouble Shooting

iVAC 2L Trouble Shooting

iVAC 2L Trouble Shooting

iVAC 2L Trouble Shooting

iVAC 2L Trouble Shooting

iVAC 2L Trouble Shooting

Case-in-a-box congress - video 7

Case-in-a-box congress - video 6

Case-in-a-box congress - video 5

Case-in-a-box congress - video 4

Case-in-a-box congress - video 3

Case-in-a-box congress - video 2

Case-in-a-box congress - video 1

Case-in-a-box number 2: Al Qassimi Hospital February 2023

Case-in-a-box number 1: Al Qassimi Hospital February 2023

iVAC 2L Procedure Steps

iVAC 2L Setup

iVAC 2L Trouble Shooting

iVAC 2L Clinical Effect

Complete webinar

First evaluation of a novel pulsatile LVAD: Feasibility and haemodynamic impact in acute heart failure

Session

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok